Nektar Therapeutics (NKTR) traded down -3.7 % during a 24 hours period ending at 12:58 AM Central Europe on Tuesday 27th. One Nektar Therapeutics stock can currently be bought for about USD 37.45 on popular exchanges. Current supply of Nektar Therapeutics stocks is 34.1 mn. Nektar Therapeutics has a current market capitalization of USD 1.3 bn and approximately USD 17.5 mn worth of Nektar Therapeutics was traded on exchanges in the last 24 hours. Since last month end, Nektar Therapeutics has traded -37.32 % down. Simple moving average of last 200 days is at USD 65.01. The highest price of past 52 weeks was recorded at USD 109 on 04/20/2026. 52 weeks low was at USD 33.4 on 01/30/2026.

Here is how related stocks have performed in the past 24 hours:

  • Amalgamated (AMAL) traded up 0.38 % and now trades at USD 50.88. Current market capitalisation for Amalgamated is USD 1.5 bn. Amalgamated has a current price to earnings ratio of 12.45.

  • Dorchester Minerals (DMLP) traded up 2.2 % and now trades at USD 30.58. Dorchester Minerals has a market capitalisation of USD 1.5 bn. Current price/earnings ratio for Dorchester Minerals is 17.48.

  • Pursuit Attractions And Hosp (PRSU) traded down -2.49 % and now trades at USD 54.89. Current market capitalisation for Pursuit Attractions And Hosp is USD 1.5 bn. Pursuit Attractions And Hosp has a current price to earnings ratio of 36.75.

  • Agilon Health (AGL) traded down -0.64 % and now trades at USD 90.34. Agilon Health has a market capitalisation of USD 1.5 bn.

  • Structure Therapeutics (GPCR) traded down -3.37 % and now trades at USD 21.1. Structure Therapeutics has a market capitalisation of USD 1.5 bn.

About Nektar Therapeutics

Nektar Therapeutics is a biopharmaceutical company based in San Francisco, United States, with operations also in India. The company specializes in investigational drugs for oncology, immunology, and virology, as well as a portfolio of approved partnered medicines. Their website is www.nektar.com and they are listed on the Nasdaq stock exchange. Their initial public offering (IPO) date was May 3rd, 1994.